Cramer says Rite Aid's (RAD) big recent earnings drop should not be a red flag for Walgreen's report because Rite Aid had a transition problem with a particular drug distributor, and he wants to buy Rite Aid very aggressively.
He thinks Walgreen continues to have the favor of Wall Street because it has the ability to do inversion, the great Alliance Boots deal, a great balance sheet and a forward-looking CEO in Gregory Wasson. The stock has run a lot, but Cramer believes it can still go higher.
"We rate WALGREEN CO (WAG) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow."
Cramer also says Monsanto is the stock to play if investors want to be in the genetically-modified space. He says natural/organic is a very small percentage of the food chain, and Monsanto helps feed the world in a cheaper way. He notes Monsanto is the biotech company that allows people to get more out of corn and soy and there is an endless demand for protein and these types of products. Finally, Cramer says Monsanto has been a buy every time it has been hit, and he doesn't think this time would be any different. TheStreet Ratings team also rates Monsanto as a "buy" with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:
"We rate MONSANTO CO (MON) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow."
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV